Published:
Depomed to Present at Merriman Curhan Ford's Investor Summit 2009
MENLO PARK, Calif. - (BUSINESS WIRE) - Depomed, Inc. (NASDAQ:DEPO) announced today that its president and chief
executive officer, Carl A. Pelzel will be presenting at Merriman Curhan
Ford's 6th annual Investor Summit in New York, NY on November 10, 2009
at 1:00 pm EST.
The company will be webcasting its presentation and interested parties
can access the live or archived presentation for up to 90 days on the
company's website at www.depomed.com.
About Depomed
Depomed, Inc. is a specialty pharmaceutical company with one product
candidate through Phase 3 clinical development, another in Phase 3
clinical development, two approved products on the market and other
product candidates in its early stage pipeline. Product candidate
DM-1796 has completed Phase 3 clinical development and has been licensed
to Solvay Pharmaceuticals. A New Drug Applications for DM-1796 is
expected to be filed with the FDA in the first quarter of 2010. Product
candidate SeradaTM is in Phase 3 clinical development for menopausal hot
flashes. GLUMETZA(R) (metformin hydrochloride extended release tablets)
is approved for use in adults with type 2 diabetes and promoted by
Santarus, Inc. in the United States. Depomed formulates its products and
product candidates with its proven, proprietary Acuform(R) drug delivery
technology, which is designed to improve existing oral medications,
allowing for extended, controlled release of medications to the upper
gastrointestinal tract. Benefits of Acuform-enhanced pharmaceuticals
include the convenience of once-daily administration, improved treatment
tolerability and enhanced compliance and efficacy. Additional
information about Depomed may be found on its website, www.depomed.com.
About Merriman Curhan Ford
Merriman Curhan Ford (NASDAQ:MERR) is a financial services firm focused
on fast-growing companies and the institutions that invest in them. The
company offers high-quality investment banking, equity research,
institutional services and corporate & venture services, and specializes
in five growth industry sectors: CleanTech, Consumer, Media & Internet,
Health Care, Natural Resources and Technology. For more information,
please go to www.mcfco.com.
Depomed, Inc.
Sheilah Serradell, 650-462-5900
sserradell@depomed.com
Copyright © 2009, Business Wire, Inc., All rights reserved.
Copyright © 2009, NewsBlaze,
Daily NewsTags: Business wire, Healthcare, california, new york, Health, Biotechnology, Pharmaceuticals
Search News
Daily News
